|
|
Name: |
Opaleye Management Inc. |
City: |
Cambridge |
State: |
MA |
Zip: |
02140 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
51 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
HROW |
Harrow Health Inc |
1 |
- |
$30.88 |
$105,203,000 |
3,955,000 |
24% |
-28,662,000 |
-35,000 |
15.359 |
Biotechnology |
|
ETON |
Eton Pharmaceuticals, Inc. |
2 |
- |
$0.00 |
$37,020,000 |
2,852,070 |
8.45% |
-970,000 |
0 |
16.196 |
N/A |
|
LQDA |
Liquidia Technologies Inc |
4 |
- |
$13.10 |
$33,335,000 |
2,260,000 |
7.61% |
13,365,000 |
561,858 |
2.943 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
5 |
- |
$62.73 |
$25,955,000 |
490,000 |
5.92% |
-2,035,000 |
-10,000 |
0.691 |
N/A |
|
CDXS |
Codexis Inc |
6 |
- |
$2.39 |
$25,555,000 |
9,500,000 |
5.83% |
-16,612,000 |
660,000 |
14.642 |
Biotechnology |
|
IMNM |
Immunome Inc. |
7 |
- |
$8.77 |
$23,892,000 |
3,550,000 |
5.45% |
2,227,000 |
1,510,000 |
6.377 |
N/A |
|
TGTX |
TG Therapeutics Inc |
8 |
- |
$36.72 |
$21,095,000 |
535,000 |
4.81% |
-46,931,000 |
-1,725,000 |
0.415 |
Drug Manufacturers - ... |
|
ARVN |
Arvinas Holding Company, Llc |
9 |
- |
$7.54 |
$13,865,000 |
1,975,000 |
3.16% |
-19,778,000 |
350,000 |
2.209 |
N/A |
|
OCUL |
Ocular Therapeutix, Inc |
10 |
- |
$0.00 |
$11,691,000 |
1,595,000 |
2.67% |
-25,394,000 |
-2,747,500 |
1.023 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
11 |
- |
$13.17 |
$8,690,000 |
395,000 |
1.98% |
-4,126,000 |
-85,000 |
0.383 |
N/A |
|
TARA |
Protara Therapeutics, Inc |
12 |
- |
$2.88 |
$7,370,000 |
1,730,000 |
1.68% |
-2,266,000 |
-95,000 |
16.461 |
N/A |
|
DNA |
Ginkgo Bioworks Holdings, Inc |
13 |
- |
$9.46 |
$6,812,000 |
1,195,000 |
1.55% |
-4,972,000 |
-5,000 |
0.069 |
N/A |
|
ANIK |
Anika Therapeutics Inc |
14 |
New |
$10.74 |
$5,937,000 |
395,000 |
1.35% |
5,937,000 |
395,000 |
2.735 |
Biotechnology |
|
PTGX |
Protagonist Therapeutics, Inc |
15 |
- |
$55.69 |
$5,078,000 |
105,000 |
1.16% |
1,025,000 |
0 |
0.164 |
N/A |
|
XOMA |
XOMA Corporation |
16 |
- |
$27.49 |
$5,043,000 |
253,043 |
1.15% |
-1,527,000 |
3,043 |
2.245 |
Biotechnology |
|
TRVI |
Trevi Therapeutics, Inc. |
17 |
- |
$0.00 |
$5,001,000 |
795,000 |
1.14% |
-4,547,000 |
-1,522,500 |
0.781 |
N/A |
|
PVLA |
Palvella Therapeutics Inc |
18 |
New |
$22.08 |
$4,824,000 |
172,357 |
1.1% |
4,824,000 |
172,357 |
13.057 |
N/A |
|
GOSS |
Gossamer Bio Inc |
19 |
- |
$1.25 |
$4,716,000 |
4,287,415 |
1.08% |
654,000 |
-202,585 |
1.902 |
N/A |
|
ANAB |
Anaptysbio Inc |
20 |
New |
$22.47 |
$4,665,000 |
250,933 |
1.06% |
4,665,000 |
250,933 |
0.717 |
N/A |
|
IRON |
Disc Medicine, Inc |
21 |
New |
$54.50 |
$4,219,000 |
85,000 |
0.96% |
4,219,000 |
85,000 |
0.286 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
22 |
New |
$1.15 |
$4,115,000 |
1,914,077 |
0.94% |
4,115,000 |
1,914,077 |
2.865 |
N/A |
|
CGON |
CG Oncology, Inc |
23 |
New |
$25.95 |
$4,016,000 |
163,988 |
0.92% |
4,016,000 |
163,988 |
0.248 |
N/A |
|
SLRN |
Acelyrin, Inc. |
24 |
- |
$2.27 |
$3,989,000 |
1,615,000 |
0.91% |
-3,186,000 |
-620,000 |
1.662 |
N/A |
|
RCEL |
Avita Therapeutics Inc |
25 |
New |
$6.09 |
$3,582,000 |
440,000 |
0.82% |
3,582,000 |
440,000 |
2.035 |
N/A |
|
EPIX |
ESSA Pharma Inc |
26 |
- |
$0.00 |
$3,492,000 |
2,209,998 |
0.8% |
-464,000 |
0 |
5.025 |
Diagnostic Substances |
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
27 |
- |
$1.18 |
$3,156,000 |
1,985,000 |
0.72% |
-2,200,000 |
217,500 |
2.284 |
N/A |
|
CRGX |
Cargo Therapeutics, Inc. |
28 |
- |
$0.00 |
$2,713,000 |
666,503 |
0.62% |
-8,102,000 |
-83,497 |
0 |
N/A |
|
ZYME |
Zymeworks Inc |
29 |
New |
$12.47 |
$2,084,000 |
175,000 |
0.48% |
2,084,000 |
175,000 |
0.25 |
N/A |
|
BDSX |
Biodesix Inc |
30 |
- |
$0.00 |
$2,016,000 |
3,225,000 |
0.46% |
-3,285,000 |
-240,000 |
2.221 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
31 |
- |
$11.63 |
$1,995,000 |
300,000 |
0.46% |
1,719,000 |
275,000 |
0.479 |
N/A |
|
MBX |
Mbx Biosciences, Inc. |
32 |
New |
$0.00 |
$1,845,000 |
250,000 |
0.42% |
1,845,000 |
250,000 |
0.748 |
N/A |
|
OPTN |
OptiNose Inc |
33 |
New |
$9.60 |
$1,770,000 |
193,039 |
0.4% |
1,770,000 |
193,039 |
1.919 |
N/A |
|
OCUP |
Ocuphire Pharma, Inc |
34 |
New |
$0.98 |
$1,546,000 |
1,175,000 |
0.35% |
1,546,000 |
1,175,000 |
10.8 |
Biotechnology |
|
IBIO |
Ibio Ord Shs |
35 |
- |
$0.20 |
$1,508,000 |
375,000 |
0.34% |
589,000 |
0 |
0.417 |
Drug Manufacturers - ... |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
36 |
New |
$28.04 |
$1,388,000 |
62,501 |
0.32% |
1,388,000 |
62,501 |
0.155 |
N/A |
|
NRIX |
Nurix Therapeutics, Inc. |
37 |
- |
$0.00 |
$1,366,000 |
115,000 |
0.31% |
-5,765,000 |
-263,500 |
0.162 |
N/A |
|
RZLT |
Rezolute, Inc |
38 |
- |
$4.35 |
$1,349,000 |
465,000 |
0.31% |
-930,000 |
0 |
0.84 |
N/A |
|
SGMO |
Sangamo Biosciences Inc |
39 |
New |
$0.52 |
$692,000 |
1,055,000 |
0.16% |
692,000 |
1,055,000 |
0.748 |
Biotechnology |
|
PEPG |
Pepgen Inc. |
40 |
- |
$1.15 |
$590,000 |
420,000 |
0.13% |
173,000 |
310,000 |
1.289 |
N/A |
|
DERM |
Journey Medical Ord Shs |
41 |
New |
$0.00 |
$409,000 |
69,323 |
0.09% |
409,000 |
69,323 |
0.65 |
N/A |
|
VTYX |
Ventyx Biosciences, Inc. |
42 |
- |
$2.34 |
$219,000 |
190,000 |
0.05% |
-394,000 |
-90,000 |
0.269 |
N/A |
|
ADGM |
Adagio Medical Holdings, Inc. |
43 |
- |
$1.27 |
$92,000 |
110,571 |
0.02% |
-24,000 |
0 |
0.826 |
N/A |
|
NUVL |
Nuvalent, Inc. |
52 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,579,000 |
-58,500 |
0 |
N/A |
|
IMTX |
Immatics N.V |
45 |
Closed |
$5.43 |
$0 |
0 |
0% |
-1,173,000 |
-165,000 |
0 |
N/A |
|
ABCL |
Abcellera Biologics Inc. |
51 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,827,000 |
-965,000 |
0 |
N/A |
|
JSPR |
Jasper Therapeutics Ord Shs |
44 |
Closed |
$15.12 |
$0 |
0 |
0% |
-8,552,000 |
-400,000 |
0 |
N/A |
|
RGNX |
Regenxbio Inc. |
50 |
Closed |
$8.39 |
$0 |
0 |
0% |
-618,000 |
-80,000 |
0 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
49 |
Closed |
$13.49 |
$0 |
0 |
0% |
-2,343,000 |
-220,000 |
0 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
48 |
Closed |
$0.00 |
$0 |
0 |
0% |
-6,140,000 |
-75,000 |
0 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
47 |
Closed |
$0.00 |
$0 |
0 |
0% |
-8,353,000 |
-325,000 |
0 |
N/A |
|
LXEO |
Lexeo Therapeutics, Inc. |
46 |
Closed |
$0.00 |
$0 |
0 |
0% |
-855,000 |
-130,000 |
0 |
N/A |
|